200HO11772 MANHATTAN

Print/PDF
Registration Name PROGENESIS MANHATTAN-ET
Registration Number HOCAN000013353569
Primary NAAB Code 200HO11772
Secondary Code(s) 777HO11772
Status Inactive
Controller Name Semex Alliance (200)
Date of Birth 2/18/2019
aAa 234516
DMS 561,135
GFI 12.2%
Genetic Codes * TD TL TR TV TY TC TP MW
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T
Sire PROGENESIS POSITIVE
MGS WESTCOAST GUARANTEE-ET
Beta Casein A1A2
Kappa Casein AB
Beta Lactoglobulin -
INDEXES
NM$ 346, 89% R CM$ 372
NM Percentile 36% FM$ 292
GTPI 2882 GM$ 326
PRODUCTION TRAITS
732 Dtrs 313 herds 24 % US 97% R
Milk 462 Fat, % 57 , +0.14%
SCS 2.66, 95% R Protein, % 27 , +0.04%
Feed Saved -243 , 58% R Milking Speed 6.98 , 74% R
Health & Fertility
Productive Life 0.5      93% R Mastitis 3.3      84% R
Heifer Livability -1.3       65% R Metritis 1.3      78% R
Livability -       81% R D. Abom -0.3      81% R
DPR -0.3      94% R Ketosis 0.8      76% R
FSC 1.0      93% R R. Placenta 0.6      78% R
HCR -1.3      88% R Milk Fever -0.1      69% R
CCR -0.3      93% R
SCR -        -
DIA -2.2      53% R
RSP -2.3      61% R
Calving Traits
Sire CE 1.3      91% R 972 Obs
Daughter CE 1.4      88% R 150 Obs, 452 Dtrs
Sire SB 3.1      83% R 1020 Obs
Daughter SB 3.9      86% R 148 Obs, Dtrs
Gestation Length -1.5      97% R 40 Obs, 248 Dtrs
Early First Calving -2.2      87% R 46 Obs, 149 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
564 Dtrs 245 herds 96% R
PTA Type 0.47 UDC 0.60
HCC -0.14 BWC 0.70
FLC -1.00
Linear Traits
Stature 1.16
Tall
Strength 0.55
Strong
Body Depth 0.38
Deep
Dairy Form 0.37
Open
Rump Angle 2.40
Sloped
Thurl Width 1.08
Sloped
Rear Legs-Side View 1.08
Wide
Rear Legs-Rear View -1.14
H.-in
Foot Angle 0.28
Steep
Feet & Legs Score -0.58
Low
F.U. Attachment -1.10
Straight
Rear Udder Height 0.63
High
Rear Udder Width 0.97
Wide
Udder Cleft -0.84
Weak
Udder Depth -1.14
H.-in
Front Teat Placement -0.11
Wide
Rear Teat Placement -0.57
Wide
Teat Length -0.44
Short
-2
0
2

CDCB August 2026; Base of Evaluation: HO